Benin vs Tanzania, United Republic of: Antiretroviral therapy coverage
Benin
87.0%
in 2024
Tanzania, United Republic of
87.0%
in 2024
Benin rank
29th
Tanzania, United Republic of rank
29th
Antiretroviral therapy coverage over time
- Benin
- Tanzania, United Republic of
How they compare
Benin currently reports 87.0% against 87.0% in Tanzania, United Republic of, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Tanzania, United Republic of ahead.
Benin ranks 29th and Tanzania, United Republic of ranks 29th of 143 countries.
Across the 3 decades both report, Benin averaged higher in 2 and Tanzania, United Republic of in 1.
Head to head by decade
| Decade | Benin | Tanzania, United Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.4% | 5.0% | 0.6% | Tanzania, United Republic of |
| 2010s | 42.5% | 40.3% | 2.2% | Benin |
| 2020s | 80.6% | 75.4% | 5.2% | Benin |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Benin or Tanzania, United Republic of?
- Benin, at 87.0% against 87.0% in Tanzania, United Republic of as of 2024.
- What is the difference in antiretroviral therapy coverage between Benin and Tanzania, United Republic of?
- 0.0%, with Benin ahead.
- How many years of comparable data are there for Benin and Tanzania, United Republic of?
- 25 years are reported by both, from 2000 to 2024.
- How do Benin and Tanzania, United Republic of rank globally for antiretroviral therapy coverage?
- Benin ranks 29th and Tanzania, United Republic of ranks 29th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.